|
Volumn 487, Issue , 2009, Pages 451-466
|
Therapeutic targeting of gene expression by siRNAs directed against BCR-ABL transcripts in a patient with imatinib-resistant chronic myeloid leukemia.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BCR ABL PROTEIN;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
SMALL INTERFERING RNA;
ARTICLE;
CASE REPORT;
CHRONIC MYELOID LEUKEMIA;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
FEMALE;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETICS;
HUMAN;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PHILADELPHIA 1 CHROMOSOME;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
FUSION PROTEINS, BCR-ABL;
GENE EXPRESSION REGULATION, LEUKEMIC;
GENE THERAPY;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MIDDLE AGED;
PHILADELPHIA CHROMOSOME;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
RNA, SMALL INTERFERING;
MLCS;
MLOWN;
|
EID: 64549098232
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-60327-547-7_22 Document Type: Article |
Times cited : (16)
|
References (0)
|